The opioid analgesic, Sufentanil, is an analog of fentanyl, and has been used for induction and maintenance of anesthesia, and postoperative analgesic. It has a short shelf life and elimination half-life and is a more potent pain reliever than fentanyl. However, clinically, water fentanyl administered intravenously produces anesthesia substantially equivalent to fentanyl, and is an anesthetic superior to morphine or pedidine (meperidine) for major surgery. During surgery, it appears to maintain hemodynamic stability over other opioids or inhalation anesthetics. Postoperative suppression of breath was reported in several patients. For outpatient surgery, intravenous fentanyl produces anesthesia equivalent to isoflurane or fentanyl.

Get Sample Copy of Sufentanil (API) Market at: https://www.orionmarketreports.com/sufentanil-api-market/37295/#ert_pane1-1

Key market players
Major competitors identified in this market include Kern Pharma, Cambrex, Hameln Rds, Cristalia, Janssen Pharmaceuticals, etc.

Based on the Type:

• Purity 98%
• Purity 99%

Based on the Application:

• Injection
• Capsule

A full report of Global Sufentanil (API) Market is available at: https://www.orionmarketreports.com/sufentanil-api-market/37295/

Scope of the Report

The research study analyses the global Sufentanil (API) industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Sufentanil (API) Market Report

1. What was the Sufentanil (API) Market size in 2018 and 2019; what are the estimated growth trends and market forecast (2019-2025).
2. What will be the CAGR of Sufentanil (API) Market during the forecast period (2019-2025)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2018? How these segments are expected to grow during the forecast period (2019-2025).
4. Which manufacturer/vendor/players in the Sufentanil (API) Market was the market leader in 2018?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

For more customized data, request for report customization @ https://www.orionmarketreports.com/sufentanil-api-market/37295/#ert_pane1-2



About Us:

Orion Market Reports (OMR) endeavours to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404